ShareValue scores for 8329.HK: Valuation 68, Quality 44, Growth 31, Health 54.

8329.HK
HKEX

Shenzhen Neptunus Interlong Bio technique Co Ltd

HK$0.10(-7.48%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

6% to 17%
Valuation
68
Fair Value
Price vs Value
Quality
44
Moderate
Business Strength
Growth
31
Weak
Revenue & Earnings
Health
54
Moderate
Financial Stability
Momentum
47
Neutral
Price Trend

Company Details

About

Shenzhen Neptunus Interlong Bio-technique Company Limited, together with its subsidiaries, engages in the research and development, manufacturing, and selling of medicines and medical devices in the People's Republic of China. It operates through two segments, Manufacturing and Selling of medicines and medical devices; and Sales and Distribution of medicines and healthcare products, and medical devices. The company offers medicines for various therapeutic areas, including oncology, cardiovascular system, respiratory system, digestive system, and mental diseases. It is also involved in the purchase, sale, and distribution of medicines and healthcare food products; and research and development of biological technology business. Shenzhen Neptunus Interlong Bio-technique Company Limited was incorporated in 2002 and is based in Quarry Bay, Hong Kong. Shenzhen Neptunus Interlong Bio-technique Company Limited operates as a subsidiary of Shenzhen Neptunus Bio-engineering Company Limited.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026